S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.
about
Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.Comparative quantitative proteomic analysis of disease stratified laser captured microdissected human islets identifies proteins and pathways potentially related to type 1 diabetesS100 Proteins As an Important Regulator of Macrophage Inflammation.Imaging, myeloid precursor immortalization, and genome editing for defining mechanisms of leukocyte recruitment in vivo.
P2860
S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
S100A8/A9, a potent serum and ...... gative experimental arthritis.
@en
S100A8/A9, a potent serum and ...... gative experimental arthritis.
@nl
type
label
S100A8/A9, a potent serum and ...... gative experimental arthritis.
@en
S100A8/A9, a potent serum and ...... gative experimental arthritis.
@nl
prefLabel
S100A8/A9, a potent serum and ...... gative experimental arthritis.
@en
S100A8/A9, a potent serum and ...... gative experimental arthritis.
@nl
P2093
P2860
P1476
S100A8/A9, a potent serum and ...... gative experimental arthritis.
@en
P2093
Annet W Sloetjes
Dirk Foell
Edwin J W Geven
Fons A J van de Loo
Giuliana Ascone
Irene Di Ceglie
Johannes Roth
Marije I Koenders
Martijn H J van den Bosch
Michael Schäfers
P2860
P2888
P356
10.1186/S13075-016-1121-Z
P577
2016-10-24T00:00:00Z
P6179
1050629772